Original

Factors determining hyperhomocysteinemia in the chronic phase of strokes

F.J. Carod-Artal, S.V Nunes, A.P. Vargas, D. Portugal [REV NEUROL 2007;44:513-519] PMID: 17492607 DOI: https://doi.org/10.33588/rn.4409.2006364

OPEN ACCESS

Volumen 44 | Number 09 | Nº of views of the article 4.362 | Nº of PDF downloads 524 | Article publication date 01/05/2007

Download PDF Castellano Citation Search in PubMed

Share in:

Go to another issue

ABSTRACT

INTRODUCTION Several prospective and case-control studies have pointed to an association between hyperhomocysteinemia and ischaemic stroke.

AIM To analyse the main factors determining hyperhomocysteinemia in the chronic phase of strokes.

PATIENTS AND METHODS We studied 280 patients with ischaemic stroke (130 subjects < 45 years old; 150 > 45 years old; 50.7% males) who were admitted to the Neurology Service consecutively over the years 2002 and 2003. Both plasma levels of homocysteine (Hc) and the mutation of the gene for 5, 10-methylenetetrahydrofolate reductase (MTHFR) were determined. An analysis was conducted to determine the distribution of the mean levels of Hc according to the aetiological subtype of stroke (TOAST classification) and the presence of vascular risk factors.

RESULTS Hc levels were found to be above normal (> 13 µmol/L) in 44.3% of cases. Hyperhomocysteinemia was more frequent in those above the age of 45 (55.3 versus 31.5%; p < 0.01). The mean Hc value was 16.3 µmol/L and was high both in young patients (15.1 ± 14.9 µmol/L) and in adults (17.4 ± 9.1 µmol/L). Results showed that 42.5% were carriers of the C677T mutation (7.1% in homozygosis and 35.4% in heterozygosis). There were more young patients carrying the homozygotic mutation than adults (9.2 versus 5.3%; p = 0.05). Hc levels in plasma were significantly higher (p< 0.01) in patients who were carriers of the homozygotic mutation (29.4 versus 14.2 µmol/L). The main factors determining hyperhomocysteinemia in the multiple linear regression analysis were: age, mutation of the gene for MTHFR, smoking and being male (R= 0.386). CONCLUSION. Genetic and environmental factors determine the levels of Hc in the chronic phase of strokes. CategoriesNeuropediatría Patología vascular

FULL TEXT (solo disponible en lengua castellana / Only available in Spanish)

Acceso directo al último número

Último Podcast

Original

Factors determining hyperhomocysteinemia in the chronic phase of strokes

¡CONVIÉRTASE EN USUARIO PREMIUM DE NEUROLOGIA.COM!

Al hacerse premium, está apoyándonos para que Revista de Neurología siga siendo uno de los referentes de habla hispana en la difusión del conocimiento en neurociencias. ¡Gratuita tanto para autores como para todos los usuarios de la web!